B. Riley Securities Maintains Buy on LifeMD, Lowers Price Target to $8

Benzinga Newsdesk www.benzinga.com Neutral 52.3%

Neg 0% Neu 52.3% Pos 0%

B. Riley Securities analyst William Woods maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $10 to $8.